Literature DB >> 19876636

Two-stage revision surgery for hip prosthesis infection using antibiotic-loaded porous hydroxyapatite blocks.

Iori Takigami1, Yoshiki Ito, Daichi Ishimaru, Hiroyasu Ogawa, Nobuyuki Mori, Takashi Shimizu, Nobuo Terabayashi, Katsuji Shimizu.   

Abstract

BACKGROUND: Infection of a hip prosthesis is one of the most severe complications encountered in orthopedic practice. Two-stage reconstruction using an antibiotic-impregnated cement spacer has become a popular procedure for the treatment of this condition. However, there are some disadvantages with the use of antibiotic-loaded cement, including low biocompatibility, a very low release ratio, and the possibility of thermal damage to the antibiotic. We have developed an effective drug delivery system for osteomyelitis in which porous hydroxyapatite (HA) blocks are loaded with an antibiotic by the vacuum method. We report here a modification of this delivery system applied for the first stage of two-stage reconstruction surgery against infected hip prosthesis. PATIENTS AND METHODS: Eight consecutive patients who developed hip prosthesis infection underwent two-stage revision total hip arthroplasty (THA) using antibiotic-loaded porous HA blocks prepared by the vacuum method. Thorough debridement and insertion of antibiotic-loaded HA blocks was performed in the first stage, followed by conversion to THA after eradication of infection in the second stage.
RESULTS: The mean interval between the stages was 16.8 weeks. There were no complications related to the use of the antibiotic-loaded HA blocks. The patients were followed up for an average of 49 months with no evidence of recurrent infection. The mean Japanese Orthopedic Association hip score improved from 45.1 before surgery to 79.6 at the latest follow-up.
INTERPRETATION: This simple approach utilizing antibiotic-impregnated HA blocks prepared by the vacuum method is considered to be effective for treatment of hip prosthesis infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19876636     DOI: 10.1007/s00402-009-0991-9

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  8 in total

Review 1.  [Replacement of infected knee and hip endoprostheses].

Authors:  M Militz; V Bühren
Journal:  Chirurg       Date:  2010-04       Impact factor: 0.955

Review 2.  Biomaterials approaches to treating implant-associated osteomyelitis.

Authors:  Jason A Inzana; Edward M Schwarz; Stephen L Kates; Hani A Awad
Journal:  Biomaterials       Date:  2015-12-18       Impact factor: 12.479

3.  Partial two-stage exchange for infected total hip arthroplasty: a preliminary report.

Authors:  Timothy E Ekpo; Keith R Berend; Michael J Morris; Joanne B Adams; Adolph V Lombardi
Journal:  Clin Orthop Relat Res       Date:  2014-02       Impact factor: 4.176

4.  Two stage revision hip arthroplasty in periprosthetic joint infection. Comparison study: with or without the use of a spacer.

Authors:  Dariusz Marczak; Marek Synder; Marcin Sibiński; Michał Polguj; Julian Dudka; Jacek Kowalczewski
Journal:  Int Orthop       Date:  2017-05-18       Impact factor: 3.075

5.  Two-stage treatment of hip periprosthetic joint infection is associated with a high rate of infection control but high mortality.

Authors:  Keith R Berend; Adolph V Lombardi; Michael J Morris; Adam G Bergeson; Joanne B Adams; Michael A Sneller
Journal:  Clin Orthop Relat Res       Date:  2013-02       Impact factor: 4.176

6.  Chronic infections in hip arthroplasties: comparing risk of reinfection following one-stage and two-stage revision: a systematic review and meta-analysis.

Authors:  Jeppe Lange; Anders Troelsen; Reimar W Thomsen; Kjeld Søballe
Journal:  Clin Epidemiol       Date:  2012-03-27       Impact factor: 4.790

Review 7.  Does cemented or cementless single-stage exchange arthroplasty of chronic periprosthetic hip infections provide similar infection rates to a two-stage? A systematic review.

Authors:  D A George; N Logoluso; G Castellini; S Gianola; S Scarponi; F S Haddad; L Drago; C L Romano
Journal:  BMC Infect Dis       Date:  2016-10-10       Impact factor: 3.090

Review 8.  Bone substitutes: a review of their characteristics, clinical use, and perspectives for large bone defects management.

Authors:  Gabriel Fernandez de Grado; Laetitia Keller; Ysia Idoux-Gillet; Quentin Wagner; Anne-Marie Musset; Nadia Benkirane-Jessel; Fabien Bornert; Damien Offner
Journal:  J Tissue Eng       Date:  2018-06-04       Impact factor: 7.813

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.